tm logo
Live/Registered
REGISTERED

on 11 Oct 2022

Last Applicant/ Owned by

88 Sidney Street

Cambridge

MA

021394169

Serial Number

90768967 filed on 11th Jun 2021

Registration Number

6874041 registered on 11th Oct 2022

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC

RALEIGH, NC 27609

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

Logo Mark Trademark Information

Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia


First Use Date in General

25th Feb 2022

First Use Date in Commerce

25th Feb 2022

Mark Details


Serial Number

No 90768967

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.01.05 -

Stars with seven or more points

24.17.15 -

Check marks

26.17.12 -

Chevrons and angles

Legal History


Show more

Status DateAction Taken
11th Oct 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
11th Oct 2022REGISTERED-PRINCIPAL REGISTER
03rd Sep 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Sep 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
31st Aug 2022STATEMENT OF USE PROCESSING COMPLETE
27th Aug 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
21st Jun 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
02th Jun 2022USE AMENDMENT FILED
02th Jun 2022TEAS STATEMENT OF USE RECEIVED
09th Feb 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED